WASHINGTON, D.C. – Statement of John Rother, executive director of the Campaign for Sustainable Rx Pricing, on today’s U.S. House Oversight Committee hearing examining pricing strategies of the pharmaceutical industry:
“Prescription drug cost hikes are not limited to companies run by people like Martin Shkreli; they are commonplace in the pharmaceutical industry. This issue transcends political party lines because consumers, patients, and public programs across the country simply cannot afford higher prices for medication. Today I was glad to see Members of Congress from both sides of the aisle join us in standing up for hardworking Americans. The time has come for Congress to expand its investigation to companies that are doing this every day. ”
—
In case you missed it, get the facts on the widespread problem of rising prescription drug prices.